Pages that link to "Q53254173"
Jump to navigation
Jump to search
The following pages link to Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease. (Q53254173):
Displaying 24 items.
- Dynamic profiling of the post-translational modifications and interaction partners of epidermal growth factor receptor signaling after stimulation by epidermal growth factor using Extended Range Proteomic Analysis (ERPA) (Q24294659) (← links)
- Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease (Q30845482) (← links)
- Parallel data acquisition of in-source fragmented glycopeptides to sequence the glycosylation sites of proteins (Q31055040) (← links)
- Biomarkers in translational research of Alzheimer's disease (Q33556189) (← links)
- Glycoproteomics in neurodegenerative diseases (Q33563387) (← links)
- Searching for reliable premortem protein biomarkers for prion diseases: progress and challenges to date (Q34342895) (← links)
- Cerebrospinal fluid protein biomarkers for Alzheimer's disease (Q36045282) (← links)
- Mass spectrometry-based proteomics and peptidomics for biomarker discovery in neurodegenerative diseases (Q36974613) (← links)
- Acetylcholinesterase and apoptosis. A novel perspective for an old enzyme (Q37060537) (← links)
- Glycosylation and other PTMs alterations in neurodegenerative diseases: Current status and future role in neurotrauma (Q37130046) (← links)
- Comparative glycoproteomics: approaches and applications (Q37171039) (← links)
- Proteomic profiling of phosphoproteins and glycoproteins responsive to wild-type alpha-synuclein accumulation and aggregation (Q37184830) (← links)
- Mass Spectrometry-based Proteomics and Peptidomics for Systems Biology and Biomarker Discovery (Q37552845) (← links)
- Multiplexed Antibody Arrays for The Discovery and Validation of Glycosylated Protein Biomarkers (Q37810156) (← links)
- LC-MS/MS in the routine clinical laboratory: has its time come? (Q38171274) (← links)
- Glycosylation of the sodium channel β4 subunit is developmentally regulated and involves in neuritic degeneration (Q39354416) (← links)
- Biological markers in Alzheimer's disease (Q40217893) (← links)
- Interplay between protein glycosylation pathways in Alzheimer's disease. (Q41723383) (← links)
- Large-scale studies of the functional K variant of the butyrylcholinesterase gene in relation to Type 2 diabetes and insulin secretion (Q44982600) (← links)
- Aryl acylamidase activity on acetylcholinesterase is high during early chicken brain development (Q45030092) (← links)
- Structural and quantitative comparison of cerebrospinal fluid glycoproteins in Alzheimer's disease patients and healthy individuals (Q46742907) (← links)
- Laminar distribution of neurotransmitter receptors in different reeler mouse brain regions. (Q51876115) (← links)
- Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease. (Q53313228) (← links)
- Early Stage Glycosylation Biomarkers in Alzheimer's Disease (Q93102873) (← links)